SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acu

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Sweden , Texas , United States , Stockholm , Houston , Tapan Kadia , Bruce Mackle , Genfleet Therapeutics Shanghai Inc , University Of Texas Md Anderson Cancer Center , Department Of Leukemia , Lifesci Advisors , Life Sciences Group Inc , Memorial Sloan Kettering Cancer Center , Nasdaq , European School Of Haematology Acute Leukaemias , Sciences Group , Haematology Acute Leukaemias , Treat Acute Leukaemias , Escalation Study , Acute Myeloid Leukemiasession Date , Leukemia Treatment Challenges Presenter , Cancer Center , Texasabstract Number , Genfleet Therapeutics , Annual Report , Sci Advisors ,